Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02297217 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Chemoradiotherapy for Advanced Esophageal Cancer

Study acronym: PaRCUS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 30, 2024 to Apr 30, 2027
    • Study completion date: Apr 30, 2025 to Apr 30, 2028
    v8
  2. Primary completion date: Apr 30, 2022 to Apr 30, 2024
    • Study completion date: Apr 30, 2023 to Apr 30, 2025
    v7
  3. Site contact updatedv6
  4. Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Primary completion date: Apr 30, 2020 to Apr 30, 2022
    • Start date changed from estimate of May 1, 2018 to Nov 21, 2019
    • Study sites: 0 to 1
    • Study completion date: Apr 30, 2021 to Apr 30, 2023
  5. Primary completion date: Dec 2017 to Apr 30, 2020v4 Show 6 more changesShow less
    • Start date: Sep 2016 to May 1, 2018
    • Primary endpoint revised
    • Study completion date: Dec 2018 to Apr 30, 2021
    • Eligibility criteria expanded, about 158 words
    • Secondary endpoints: details revised at 1 of 1 entry
    • Study description expanded, about 1 word
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Dec 2016 to Dec 2017
    • Start date: Feb 2015 to Sep 2016
    v3
  2. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to show that the addition of carboplatin and paclitaxel chemotherapy to a palliative course of external beam radiation treatment improves both dysphagia relief and patient quality of life in patients with unresectable esophageal cancer.
Trial Details
NCT Number NCT02297217
Lead Sponsor AHS Cancer Control Alberta
Conditions
(from sponsor)		 Esophageal Cancer
Related terms Esophageal Neoplasms
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov